Product
Esomeprazole
Aliases
Esomeprazole 20mg, Esomeprazole 20 mg Delayed-Release Capsules, Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR), Esomeprazole 40mg (1 other aliases)
35 clinical trials
33 indications
Indication
HealthyIndication
Gastrointestinal DiseasesIndication
Healthy ParticipantsIndication
HomeostasisIndication
BoneIndication
Advanced Non-small Cell Lung CancerIndication
EGFR mutationIndication
HER2 MutationIndication
Healthy Control ParticipantsIndication
Healthy SubjectsIndication
Stress Ulcer BleedingIndication
Gastroesophageal Reflux DiseaseIndication
Helicobacter pyloriIndication
Helicobacter pylori infectionIndication
AutismIndication
Autism Spectrum DisorderIndication
GastritisIndication
DyspepsiaIndication
Stomach CancerIndication
Peptic UlcerIndication
Radiation EsophagitisIndication
Locally Advanced Lung CarcinomaIndication
Gastroesophageal RefluxIndication
SepsisIndication
Septic shockIndication
ObesityIndication
Preeclampsia SevereIndication
pre-eclampsiaIndication
PreeclampsiaIndication
PretermIndication
Functional DyspepsiaIndication
Non-erosive Reflux DiseaseIndication
Preterm Birth ComplicationClinical trial
A Pilot Study Comparing LY3410738 Capsule and Tablet Formulations and Effect of a Low-fat Meal and a Proton Pump Inhibitor on the Single-dose Pharmacokinetics of LY3410738 Tablets in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-04-28
Clinical trial
A Randomized, Single Blind, Single Center, Single Dose, Two Period, Two Sequence Crossover Bioequivalence Study of Esomeprazole 20 mg Delayed-Release Capsules (Catalent, Guayama) Compared to the Esomeprazole 20 mg Delayed-Release Capsules ([Nexium 24HR] AstraZeneca Södertälje) in Healthy Adult Subjects Under Fasted ConditionsStatus: Completed, Estimated PCD: 2022-06-02
Clinical trial
Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dexlansoprazole 60 mg Delayed Release Capsules and Esomeprazole 40 mg Delayed Release Capsules on Bone Homeostasis in Healthy Postmenopausal Female SubjectsStatus: Completed, Estimated PCD: 2014-08-01
Clinical trial
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Dose-Escalation, Drug-Interaction, and Food-Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult ParticipantsStatus: Recruiting, Estimated PCD: 2024-09-15
Clinical trial
A Phase 1, Open Label, Randomized, Crossover Study to Investigate the Effect of Food and Effect of an Acid Reducing Agent on the Pharmacokinetics of BAY 2927088 in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2024-05-20
Clinical trial
A Phase 1, Open-Label, Fixed-Sequence Trial to Evaluate the Effect of Esomeprazole and Gastric pH-Altering on the Pharmacokinetics of Emraclidine in Healthy Adult ParticipantsStatus: Not yet recruiting, Estimated PCD: 2024-06-24
Clinical trial
A Phase 1, Open Label, Fixed Sequence Study to Assess the Pharmacokinetics of Brensocatib When Administered Alone and With Multiple Doses of Rifampin (CYP3A Inducer) or Esomeprazole (Proton Pump Inhibitor) in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-07-16
Clinical trial
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Treatment of Prevention of Stress Ulcer Bleeding (Ilaprazole i.v. vs Esomeprazole, i.v.)Status: Completed, Estimated PCD: 2022-04-28
Clinical trial
A Randomized, Open-label, Two-cycle Clinical Study to Evaluate the Drug Interaction, Food Effect and Pharmacokinetics of IBI351 With Esomeprazole in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-10-16
Clinical trial
A Randomized, Open-label, Three-period, Multiple Dosing Crossover Clinical Trial to Evaluate the Influence of Tegoprazan on the Pharmacodynamics of Clopidogrel in Healthy SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-11-01
Clinical trial
A Multicenter, Double-blind, Randomized, Active-controlled Phase 4 Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime HeartburnStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
The Effect of Multiple Doses of Esomeprazole on the Single-dose Pharmacokinetics of BI 1819479 Following Oral Administration in Healthy Male Subjects (an Open-label, Randomized, Two-way Cross-over Study)Status: Completed, Estimated PCD: 2023-01-23
Clinical trial
A Phase 1, Double-Blind, Parallel Group Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Quadruple Therapy (Bismuth, Clarithromycin, and Amoxicillin) With Vonoprazan Versus Quadruple Therapy With EsomeprazoleStatus: Completed, Estimated PCD: 2021-09-27
Clinical trial
A Randomized Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral TAK-438 20 mg Compared to Esomeprazole 20 mg Twice Daily in Subjects With Helicobacter Pylori InfectionStatus: Completed, Estimated PCD: 2021-11-01
Clinical trial
The Effect of High Dose Citric on PPI (Proton Pump Inhibitors)Induced False Negative H. Pylori UBT RatesStatus: Completed, Estimated PCD: 2009-11-01
Clinical trial
EU4Health Project Eurohelican: A Single-center Prospective Feasibility Study of the Proposed Test-and-treat Preventive Screening Program in Younger Slovenian Participants Aged 30-34 Years With or Without Helicobacter Pylori InfectionStatus: , Estimated PCD: 2024-12-01
Clinical trial
An Open-Label Pilot Study of Esomeprazole in Children With AutismStatus: , Estimated PCD: 2025-03-01
Clinical trial
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal MicroecologyStatus: Recruiting, Estimated PCD: 2023-12-02
Clinical trial
Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Amoxicillin 1g + Clarithromycin 500 mg and Tegoprazan 50 mg vs Amoxicillin 1g + Clarithromycin 500 mg and Esomeprazole 40 mg Twice a Day for 14 DaysStatus: Not yet recruiting, Estimated PCD: 2024-11-29
Clinical trial
Effect of Esomeprazole on Radiation Induced Esophagitis in Non-small Cell Lung Cancer (EERENs): A Phase II Single Arm StudyStatus: Recruiting, Estimated PCD: 2027-07-30
Clinical trial
The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole for 4weeks for Erosive Esophagitis Without Any AppointmentsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyStatus: Recruiting, Estimated PCD: 2024-06-06
Clinical trial
Proton Pump Inhibitors (PPI) as a New Strategy for Therapy in Sepsis: Clinical Trial to Reduce Severity of Organ Failure and in Vitro Experiments to Search Specific Hallmarks in Monocytes From Septic Patients and to Characterize the Mechanism of Action of PPIStatus: Completed, Estimated PCD: 2023-08-21
Clinical trial
Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty: a Single-centre Open-label, Randomized, Controlled Pilot Clinical TrialStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Efficacies of Tetracycline-levofloxacin Quadruple Therapy, Standard Bismuth Quadruple Therapy and Amoxicillin-levofloxacin Quadruple Therapy in the Second-line Treatment of H Pylori InfectionStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Doxycycline-containing Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-10
Clinical trial
Comparison of the Efficacy of Tegoprazan-containing Versus Esomeprazole-containing Dual Therapy for Helicobacter Pylori Eradication: a Prospective, Multicenter, Randomized Controlled Study （SHARE2301）Status: Recruiting, Estimated PCD: 2023-10-01
Clinical trial
Use of Combination Metformin and Esomeprazole in Preterm Pre-eclampsia: a Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2025-06-01
Clinical trial
Treatment Outcomes For Functional Dyspepsia Based On Current International Guidelines In Multi-Ethnic Asian PatientsStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective StudyStatus: Completed, Estimated PCD: 2020-01-05
Clinical trial
Use of Combination Metformin and Esomeprazole in Preterm Pre- Eclampsia: Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Efficacy of Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-02-06
Clinical trial
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyStatus: Completed, Estimated PCD: 2021-12-20
Clinical trial
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies.Status: Completed, Estimated PCD: 2024-02-01
Clinical trial
Efficacy of Tegoprazan-containing Sequential Therapy Compared to Proton Pump Inhibitor-based Eradication in South Korea, a Region With High Antimicrobial Resistance: A Prospective Randomized Single Tertiary Center StudyStatus: Recruiting, Estimated PCD: 2024-12-12